These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21956192)

  • 1. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study.
    Angermann CE; Störk S; Gelbrich G; Faller H; Jahns R; Frantz S; Loeffler M; Ertl G;
    Circ Heart Fail; 2012 Jan; 5(1):25-35. PubMed ID: 21956192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
    Jaarsma T; van der Wal MH; Lesman-Leegte I; Luttik ML; Hogenhuis J; Veeger NJ; Sanderman R; Hoes AW; van Gilst WH; Lok DJ; Dunselman PH; Tijssen JG; Hillege HL; van Veldhuisen DJ;
    Arch Intern Med; 2008 Feb; 168(3):316-24. PubMed ID: 18268174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.
    Cleland JG; Louis AA; Rigby AS; Janssens U; Balk AH;
    J Am Coll Cardiol; 2005 May; 45(10):1654-64. PubMed ID: 15893183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of structured heart failure disease management on mortality and morbidity depend on patients' mood: results from the Interdisciplinary Network for Heart Failure Study.
    Gelbrich G; Störk S; Kreißl-Kemmer S; Faller H; Prettin C; Heuschmann PU; Ertl G; Angermann CE
    Eur J Heart Fail; 2014 Oct; 16(10):1133-41. PubMed ID: 25142121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discharge education improves clinical outcomes in patients with chronic heart failure.
    Koelling TM; Johnson ML; Cody RJ; Aaronson KD
    Circulation; 2005 Jan; 111(2):179-85. PubMed ID: 15642765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study.
    de la Porte PW; Lok DJ; van Veldhuisen DJ; van Wijngaarden J; Cornel JH; Zuithoff NP; Badings E; Hoes AW
    Heart; 2007 Jul; 93(7):819-25. PubMed ID: 17065182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure.
    Galbreath AD; Krasuski RA; Smith B; Stajduhar KC; Kwan MD; Ellis R; Freeman GL
    Circulation; 2004 Dec; 110(23):3518-26. PubMed ID: 15531765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study.
    Conceição-Souza GE; Pêgo-Fernandes PM; Cruz Fd; Guimarães GV; Bacal F; Vieira ML; Grupi CJ; Giorgi MC; Consolim-Colombo FM; Negrão CE; Rondon MU; Moreira LF; Bocchi EA
    Eur J Heart Fail; 2012 Dec; 14(12):1366-73. PubMed ID: 23099357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study.
    Angermann CE; Kaspar M; Marx A; Kittel-Schneider S; Menhofer D; Störk S; Ertl G; Domschke K; Deckert J; Reif A
    Eur J Heart Fail; 2017 Mar; 19(3):314-323. PubMed ID: 27990720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new programme of multidisciplinary care for patients with heart failure in Poznań: one-year follow-up.
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A; Jankowiak M; Michałowicz B; Stawski W; Dziamska M; Kaszuba D; Szymanowska K; Michalski M
    Kardiol Pol; 2006 Oct; 64(10):1063-70; discussion 1071-2. PubMed ID: 17089238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF; Thygesen K; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L; Cleland JG
    J Card Fail; 2008 Oct; 14(8):670-5. PubMed ID: 18926439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women.
    Soran OZ; Piña IL; Lamas GA; Kelsey SF; Selzer F; Pilotte J; Lave JR; Feldman AM
    J Card Fail; 2008 Nov; 14(9):711-7. PubMed ID: 18995174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.